OBJECTIVES: To evaluate whether high levels of C‐reactive protein (CRP) in serum are
associated with greater risk of all‐cause dementia or mortality in the oldest‐old. DESIGN …

BACKGROUND: C-reactive protein (CRP) is a nonspecific marker of inflammation that is
increased in the brain and serum of patients with Alzheimer's disease (AD), and has been …

Background Many studies have investigated the association between markers for peripheral
inflammation and risk of dementia, but the results have been conflicting. We aimed to …

Inflammation is believed to play a pivotal role in dementia, but its role is still unclear. The aim
of our study was to analyze the interplay among markers of inflammation, such as fibrinogen …

We examined the association between differential diagnoses of major stroke and probable
Alzheimer's disease (AD) and mixed AD on C-reactive protein (CRP) in older adults with and …

C-reactive protein (CRP) is an acute-phase reactant that has been found to be associated
with Alzheimer disease (AD) in histopathological and longitudinal studies; however, little …

There is evidence for a relationship between raised inflammatory markers, including high
sensitivity C-reactive protein (hs-CRP), measured late in life, and an increased risk of …

Background: Inflammatory processes may be involved in the development of dementia,
although findings from epidemiologic studies directly examining inflammatory markers and …

Background: circulating measures of inflammatory markers, such as C-reactive protein
(CRP) have been associated with an increased risk of future cognitive decline. However, the …

Background Elevated systematic inflammation is a hallmark of aging, but the association of
long-term inflammation trajectories with subsequent aging phenotypes has been little …